Bionik Laboratories Corp Stock Buy Hold or Sell Recommendation
Given the investment horizon of 90 days and your bold attitude towards risk, our recommendation regarding Bionik Laboratories Corp is 'Strong Sell'. The recommendation algorithm takes into account all of Bionik Laboratories' available fundamental, technical, and predictive indicators you will find on this site.
Check out Bionik Laboratories Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Bionik and provide practical buy, sell, or hold advice based on investors' constraints. Bionik Laboratories Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
Bionik |
Execute Bionik Laboratories Buy or Sell Advice
The Bionik recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bionik Laboratories Corp. Macroaxis does not own or have any residual interests in Bionik Laboratories Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bionik Laboratories' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Bionik Laboratories Trading Alerts and Improvement Suggestions
| Bionik Laboratories generated a negative expected return over the last 90 days | |
| Bionik Laboratories has high historical volatility and very poor performance | |
| Bionik Laboratories has some characteristics of a very speculative penny stock | |
| Bionik Laboratories has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.27 M. Net Loss for the year was (10.41 M) with profit before overhead, payroll, taxes, and interest of 953.26 K. | |
| Bionik Laboratories Corp currently holds about 1.33 M in cash with (4.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Roughly 62.0% of the company shares are held by company insiders |
Bionik Laboratories Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bionik Laboratories or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bionik Laboratories' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bionik pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 12.60 | |
Ir | Information ratio | 0.00 |
Bionik Laboratories Volatility Alert
At this time Bionik Laboratories Corp exhibits very low volatility. You can indeed make money on Bionik instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Bionik Laboratories Fundamentals Vs Peers
Comparing Bionik Laboratories' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bionik Laboratories' direct or indirect competition across all of the common fundamentals between Bionik Laboratories and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bionik Laboratories or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Bionik Laboratories' fundamental indicators could also be used in its relative valuation, which is a method of valuing Bionik Laboratories by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bionik Laboratories to competition |
| Fundamentals | Bionik Laboratories | Peer Average |
| Return On Equity | -7.83 | -0.31 |
| Return On Asset | -0.64 | -0.14 |
| Operating Margin | (3.30) % | (5.51) % |
| Current Valuation | 4.84 M | 16.62 B |
| Shares Outstanding | 6.88 M | 571.82 M |
| Shares Owned By Insiders | 61.64 % | 10.09 % |
| Shares Owned By Institutions | 1.18 % | 39.21 % |
| Price To Earning | (3.60) X | 28.72 X |
| Price To Book | 8.04 X | 9.51 X |
| Price To Sales | 3.82 X | 11.42 X |
| Revenue | 1.27 M | 9.43 B |
| Gross Profit | 953.26 K | 27.38 B |
| EBITDA | (9.48 M) | 3.9 B |
| Net Income | (10.41 M) | 570.98 M |
| Cash And Equivalents | 1.33 M | 2.7 B |
| Cash Per Share | 0.19 X | 5.01 X |
| Total Debt | 503.47 K | 5.32 B |
| Debt To Equity | 0.32 % | 48.70 % |
| Current Ratio | 2.32 X | 2.16 X |
| Book Value Per Share | (0.08) X | 1.93 K |
| Cash Flow From Operations | (4.15 M) | 971.22 M |
| Earnings Per Share | (1.78) X | 3.12 X |
| Number Of Employees | 12 | 18.84 K |
| Beta | -1.02 | -0.15 |
| Market Capitalization | 4.27 M | 19.03 B |
| Total Asset | 4.68 M | 29.47 B |
| Retained Earnings | (10.65 M) | 9.33 B |
| Working Capital | 891 K | 1.48 B |
| Current Asset | 7.15 M | 9.34 B |
| Current Liabilities | 6.26 M | 7.9 B |
| Z Score | -4.6 | 8.72 |
| Net Asset | 4.68 M |
About Bionik Laboratories Buy or Sell Advice
When is the right time to buy or sell Bionik Laboratories Corp? Buying financial instruments such as Bionik Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bionik Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Agriculture Thematic Idea Now
Agriculture
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Agriculture theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Agriculture Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Bionik Pink Sheet
Bionik Laboratories financial ratios help investors to determine whether Bionik Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bionik with respect to the benefits of owning Bionik Laboratories security.